and finally by measuring the release of arachidonic acid. The sequential activation of phospholipase C and of protein kinase C is required for the 2-chloroadenosine-induced activation of phospholipase A2 since P-chloroadenosine markedly stimulated phospholipase C activity in the absence of methoxamine when protein kinase C was activated by a diacylglycerol analog. Finally, the enhancing effect of P-chloroadenosine on the methoxamine-evoked response seems to result from an inhibition of glutamate reuptake into astrocytes by arachidonic acid. Indeed, the potentiating effect of 2-chloroadenosine was suppressed when external glutamate was removed enzymatically and mimicked by either selective inhibitors of the glutamate reuptake process or direct application of glutamate.
Several studies indicate that adenosine modulates neuronal functions by acting both pre-and postsynaptically. Thus, adenosine has been shown either to inhibit synaptic transmission (Okada and Ozawa, 1980; Siggins and Shubert, 198 l) , to decrease the release ofneurotransmitters (Harms et al., 1976; Vizie and Knoll, 1976; Dolphin and Pestwich, 1985) , to hyperpolarize cell membranes by increasing potassium conductance (Trussel and Jackson, 1985) or to inhibit the induction of long-term potentiation (Dolphin, 1983) . In addition, adenosine receptors are also present on astrocytes; these are mainly of the A, subtype and have been shown to be negatively coupled to adenylate cyclase (Ebersolt et al., 1983) . Moreover, we have recently shown in rat striatal slices that 2-chloroadenosine, a stable analog of adenosine, potentiates the formation of inositol phosphates induced by the stimulation of CY, -noradrenergic or muscarinic receptors, also by acting on adenosine receptors of the A, subtype (El-Etr et al., 1989) . These effects were also seen in cocultures of astrocytes and neurons from the striatum of embryonic mice (El-Etr et al., 1989) . Nevertheless, 2-chloroadenosine did not enhance the o(, -adrenergic-or muscarinic-evoked activation of phospholipase C in pure neuronal primary cultures from the striatum, whereas the nucleoside enhanced the formation of inositol phosphates resulting from the activation of oc,-adrenergic receptors on pure populations of striatal astrocytes (El-Etr et al., 1989) . These observations led us to conclude that (1) astrocytes are required for the potentiation by the nucleoside of the muscarinic-induced accumulation of inositol phosphates, a response that is of neuronal origin in the striatum, and (2) the initial biochemical events involved in this astrocytoneuronal interaction occur in astrocytes. Therefore, the present study was undertaken to determine the mechanism underlying the potentiation by 2-chloroadenosine of the LY, -adrenergic-induced production of inositol phosphates in cultured striatal astrocytes from the mouse embryo.
Materials and Methods
Cell cultures. Primary cultures of astrocytes were prepared as previously described (El-Etr et al., 1989) . Striata were removed from 16-d-old Swiss mouse embryos (Iffa Credo) and were dissociated mechanically in serum-free medium. Cells were plated plated in 24-or 6-well Nunc culture dishes (2.5 x lo5 or 8 x lo5 cells per well, respectively), previously coated with poly-L-omithine (1.5 &ml; MW, 40,000; Sigma). The culture medium was composed of Minimal Essential Medium and F-12 nutrient (GIBCO, Europe) supplemented with glucose (33 mM), glutamine (2 mM), NaHCO, (3 mM), HEPES (5 mM), and 10% NU-Serum@ (Collaborative Research). Cells were cultured at 37°C for 18-20 d in a humidified atmosphere of 95% air and 5% CO,. On day 12, the medium was changed and cytosine arabinoside (1 WM; Sigma) was added for 24 hr in order to avoid the formation of cell multilayers and the proliferation of microglial cells. Thereafter, the culture medium was changed twice a week. In these conditions, more than 95% of the cells were stained by the indirect immunofluorescence technique using a rabbit antibody against glial fibrillary acid protein (GFAP) (Dakopatts, Denmark). The remaining 5% of cells could be immature'glioblasts, which are known to be unlabeled bv GFAP antibodies (Ena. 1985) . The cultures were free of microglial cells since no staining'wai'observed using the monoclonal anti-mouse macrophage antibody (anti-MAC 1) (Serotec, France). with LiCl (10 mM). Effecters were then added for 20 min (except when otherwise stated) in the presence of adenosine deaminase (1 IU/ml; Boehringer-Mannheim) in order to prevent the effect of endogenous adenosine on phospholipase C activity. When stated, glutamate pyruvate transaminase (GPT; 10 IU/ml; BoehringerMannheim), which converts glutamate into oc-ketoglutarate in the presence of a high concentration of pyruvate (1 mM), was added into the incubation medium in order to eliminate enzymatically external glutamate (O'Brien and Fischbach. 1986 ). The incubation was stonued by adding successively 0.1% Tritdn X-100/0.1 M NaOH (200 pi); 0.1% Triton X-100/0.1 M HCl (200 PI), and water (500 ~1). Cells were then scraped and 'H-inositol phosphates were extracted as previously described (El-Etr et al., 1989) .
Measurement of 3H-arachidonic acid release. Cells in 35 mm dishes were incubated for 18-22 hr with 3H-arachidonic acid (1 &i/ml, 200 Ci/mmol; CEA, France) added into the culture medium. After labeling, astrocytes were washed four times at 5 min intervals with 2 ml of a calcium-free Kreb's phosphate buffer containing fatty acid-free bovine serum albumin (1 mg/ml; Sigma) and adenosine deaminase (1 III/ml; Boehringer-Mannheim), the last wash being made with the medium supplemented with 50 PM thimerosal (mercury-[(O-carboxyphenyl)thio]-ethyl sodium salt from Sigma), an inhibitor of acyl coenzyme A lysolecithin acyl transferase. Cells were then exposed for 20 min at 37°C to the agonists in 2 ml of the same medium supplemented with 1.2 ml CaCl,. The incubation medium was then collected and centrifuged at 300x g for 10 min to remove nonadherent cells, and the supematant was measured for radioactivity. HPLC analysis: identification of arachidonic acid. Supematants were acidified to pH 3.5 with formic acid, and 2 vol of acetone were added to precipitate proteins. After centrifugation, the acetonic phase was extracted twice with 2 vol of chloroform and the organic phase was evaporated under vacuum and injected onto a reverse-phase HPLC column (ultrasphere ODS, 3 pm, Beckman). Elution was performed (1 ml/min Row rate) with a gradient of acetonitrile in water, pH 3.5. Fractions were collected and counted for radioactivity.
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Results
Involvement of calcium influx and of two G-proteins in the potentiation by 2-chloroadenosine of the methoxamine-evoked accumulation of inositol phosphates in striatal astrocytes As previously reported, when striatal astrocytes are incubated in the presence of adenosine deaminase, the activation of CY,-adrenoreceptors by noradrenaline increases the accumulation of )H-inositol phosphates in the cells (mainly 3H-inositol monophosphate, more than 90% of total 3H-inositol phosphates formed), and this response is amplified by 2-chloroadenosine, an analog of adenosine resistant to adenosine deaminase (El-Etr et al., 1989) . Similarly, in the present study, methoxamine (25 WM), a selective agonist of cy, -adrenoreceptors, increased the production of 3H-inositol phosphates in striatal astrocytes, and this effect was strongly enhanced by the combined addition of 2-chloroadenosine (10 FM) (Fig. 1) . Responses evoked by methoxamine either in the presence or absence of 2-chloroadenosine were completely suppressed by prazosin (1 PM), a specific antagonist of cu,-adrenoreceptors (methoxamine + prazosin, 104 f 8% of control).
When used alone, 2-chloroadenosine (10 PM) induced a weak production of 3H-inositol phosphates, which never exceeded 40% of the basal value ( Fig. 1 ). This response and the marked potentiation by 2-chloroadenosine of the methoxamine-evoked production of 3H-inositol phosphates were completely inhibited by the adenosine receptor antagonist 1,3-dipropyl-8-(2-amino-4-chlorophenyl)-xanthine (PACPX; 1 PM) (data not shown). The potentiating action of 2-chloroadenosine seems to require an influx of calcium since it completely disappeared in the absence of external calcium whereas, in this condition, the methoxamine-induced production of 3H-inositol phosphates was only partially decreased ( Fig. 1 ). Purinergic and a,-adrenergic receptors of striatal astrocytes are likely to be linked to different G-proteins, since a pretreatment (18 hr) of these cells with pertussis toxin (PTX; 0.1 pg/ml) selectively suppressed the en- hancing effect of2-chloroadenosine on the methoxamine-evoked production of 3H-inositol phosphates but did not affect the response of ihe CX,-agonist alone (Fig. 1) .
Involvement of arachidonic acid in the potentiating effect of 2-chloroadenosine Several observations strongly suggest that the potentiating effect of 2-chloroadenosine on the methoxamine-evoked response involves arachidonic acid formed through the activation of phospholipase A2.
(1) Nonspecific blockers of phospholipase A2 such as mepacrine (100 FM) and 4-p-bromophenacyl bromide (10 PM), which slightly inhibited the accumulation of 3H-inositol phosphates induced by methoxamine alone, completely suppressed the potentiating effect of 2-chloroadenosine. Moreover, cyclosporine A (8 PM), which has also been shown to inhibit phospholipase A2 (Fan and Lewis, 1985; Yukie et al., 1986) , suppressed the enhancing effect of 2-chloroadenosine on the methoxamineevoked response without altering the methoxamine-evoked response (Fig. 2) .
(2) Similar results were obtained when astrocytes were pretreated for 48 hr with corticosterone (0.1 PM), the natural glucocorticoid in the mouse (Fig. 2) .
(3) The involvement of arachidonic acid in the potentiating effect of 2-chloroadenosine was further confirmed by the stimulatory actions of the unsaturated fatty acids and arachidonic and linoleic acids (10 PM) (but not of the saturated fatty acid arachidic acid) on phospholipase C activity, which were additive with that evoked by methoxamine (Fig. 3) .
(4) Moreover, as expected, the accumulation of 3H-inositol phosphates evoked by the combined application of methoxamine and 2-chloroadenosine was increased neither by arachidonic acid nor by linoleic acid (Fig. 3) . Arachidonic acid seems to act directly since nordihydroguaiaretic acid (10 PM) or indomethacin (10 WM), which inhibit lipoxygenases and cyclooxygenase activities, respectively, did not impair the enhancing effect of 2-chloroadenosine on the methoxamine-evoked response (data not shown). Nevertheless, the nonmetabolizable analog of arachidonic acid 5,8,11,14 eicosa-tetrayonic acid (ETYA; 20 PM), which partially inhibited the methoxamine- induced activation of phospholipase C, completely suppressed the potentiation evoked by 2-chloroadenosine. This latter observation could suggest either an involvement of arachidonic acid metabolites of the epoxygenase pathway or a direct inhibitory effect of ETYA on some targets of arachidonic acid since, for instance, ETYA has already been shown to block the arachidonic acid-induced activation of guanylate cyclase (Gerzer et al., 1986 ).
(5) When striatal astrocytes were preincubated for 18 hr with 3H-arachidonic acid, neither methoxamine (25 PM) nor 2-chloroadenosine (10 FM) alone affected the release of the labeled unsaturated fatty acid. However, the release of )H-arachidonic acid was significantly increased (Table 1) under the combined application of the two agonists. HPLC analysis (see Materials and Methods) indicated that 99% of the released radioactive material was recovered in a peak having a retention time identical to that of authentic arachidonic acid.
(6) Finally, the addition, during the incubation period, ofBSA (0.5 mg/ml), which is known to adsorb arachidonic acid (RCf), decreased the potentiating effect of 2-chloroadenosine on the methoxamine-induced formation of 3H-inositol phosphates ( Table 2) .
Involvement of glutamate in the potentiating efect of 2-chloroadenosine It has been reported that arachidonic acid inhibits the uptake of glutamate into Miiller cells (astrocytes) of the salamander retina (Barbour et al., 1989) . Therefore, through arachidonic acid, 2-chloroadenosine in the presence of methoxamine could indirectly induce an accumulation of glutamate into the extracellular medium. In turn, glutamate could stimulate phospholipase C activity, and this could account for the potentiating effect of 2-chloroadenosine.
In fact, in our experimental conditions, glutamate (100 PM) stimulated the production of 3H-inositol phosphates (Fig. 4) , confirming that astrocytes possess glutamate receptors coupled to phospholipase C (Pearce et al., 1986 ).
With GPT Without GPT Figure 4 . Removal of external glutamate by GPT suppresses the effects of unsaturated fatty acids and glutamate or of a glutamate uptake inhibitor on the formation of 3H-inositol phosphates (IPs). Arachidonic and linoleic acids (both 10 PM), the glutamate uptake inhibitor P-methylm.-aspartic acid (Uptake inhibitor; 1 mM), and glutamate (100 NM) were added to the incubation medium in the presence of pyruvate (1 mM) either in the absence or presence of GPT. The basal formation of 3H-inositol phosphates is not altered by the presence of GPT and pyruvate, suggesting that in the absence of agonist, the external glutamate concentration is too low to stimulate phospholipase C. Results, expressed as in Figure 1 , are the means + SEM of values obtained in atypical exneriment Derformed in trinlicate. *. significantlv different CD < 0.0 1. S&dent's t test) from the b&al productTon of 3HLinositol phosphates: Two other independent experiments yielded similar results.
The involvement of glutamate in the stimulating effect of arachidonic acid on phospholipase C activity was supported by several observations.
(1) The 2-chloroadenosine-induced production of 3H-inositol phosphates observed in the presence of methoxamine was drastically reduced when external glutamate was enzymatically removed by incubating the astrocytes with GPT (Fig. 5) .
(2) Conversely, the addition of a high-affinity and Na+-dependent glutamate uptake inhibitor, @-methyl-DL-aspartic acid (1 mM), resulted in an increased production of 3H-inositol phosphates, which was of amplitude similar to that obtained with glutamate ( Fig. 4) and which disappeared in the presence of GPT (Fig. 4) . Similar responses were obtained with other glutamate uptake inhibitors such as DL-threo-P-hydroxyaspartic acid (1 mM) or DL-aspartic acid @-hydroxamate (1 mM) (Kimelberg et al., 1989) (data not shown). 182 & 14*t Fatty acid-free BSA (0.5 mg/ml) was added to the incubation medium in the absence or the presence of 2-chloroadenosine (2CA, 10 PM), methoxamine (Meth; 25 PM), or both agonists (Meth+ZCA). The addition of fatty acid-free BSA did not modify the basal production of 'H-inositol phosphates. Results, expressed as percentage above the basal formation of'H-inositol phosphates (65 50 f 260 dpm/ well) measured in the absence of any agonist, are the means + SEM of values obtained in a typical experiment performed in triplicate. *, significantly different (p < 0.01, Student's t test) from 'H-inositol phosphate production induced by methoxamine alone; t, significantly different @ < 0.0 1, Student's t test) from 'Hinositol phosphate production measured in the presence of both methoxamine and 2-chloroadenosine, but in the absence of fatty acid-free BSA. Two other independent experiments yielded similar results.
Without GPT With GPT Figure 5 . Enzymatic removal of external glutamate suppresses the enhancing effect of 2-chloroadenosine on the methoxamine-evoked formation of 3H-inositol phosphates (ZPs). GPT was added or not, as in Figure 4 , to the incubation medium in the absence or presence of either methoxamine alone (Meth; 25 PM) or both methoxamine (25 PM) and 2-chloroadenosine (10 PM) (Meth +2CA). Results, expressed as in Figure  1 , are the means ? SEM of values obtained in a typical experiment performed in triplicate. 0, significantly different @ < 0.01) from 3H-inositol phosphate production induced by methoxamine alone. Three other independent experiments yielded similar results.
(3) As expected, the inhibitor of glutamate uptake P-methylm-aspartic acid (1 mM) did not further increase the production of 3H-inositol phosphates when it was simultaneously added with both methoxamine and 2-chloroadenosine (Fig. 6) . In addition, it partially reproduced the enhancing effect of 2-chloroadenosine on the methoxamine-evoked response (Fig. 6) . (4) The stimulatory action of the two unsaturated fatty acids arachidonic and linoleic acid (but not arachidic acid) on phospholipase C activity was no longer observed in the presence of GPT (Fig. 4) .
(5) The enhancing effect of 2-chloroadenosine on the methoxamine-evoked production of 3H-inositol phosphates was only observed when the incubation period was of long duration, that is, 20 min (Fig. 7) . This delayed response likely corresponds to the time required to reach an extracellular concentration of glutamate sufficient for stimulating the activity of phospholipase C through glutamate receptors present on astrocytes.
Requirement of protein kinase C activation for the stimulatory effect of 2-chloroadenosine on phospholipase A2 activity The stimulation of oc,-adrenoreceptors seems to be necessary for the activating effect of 2-chloroadenosine on phospholipase A2 activity since in the absence of methoxamine, 2-chloroadenosine was nearly ineffective (Table 1 ). This permissive effect of methoxamine seems to be mediated by the activation of protein kinase C resulting from its stimulatory effect on phospholipase C. Supporting this statement, 2-chloroadenosine alone markedly increased the production of 3H-inositol phosphates when cells were simultaneously incubated with an activator of protein kinase C, the diacylglycerol analog 1 -oleyl-2-acetyl-rat-glycerol (OAG; 25 &ml) ( Table 3 ).
Discussion
We have previously shown that 2-chloroadenosine increases the noradrenaline-evoked production of inositol phosphates in cultured striatal astrocytes from mouse embryos (El-Etr et al., 1989) . The present study was undertaken to investigate further the mechanism involved in this phenomenon. No agonist Meth Meth+2CA Figure 6 . Effects of glutamate and of an inhibitor of glutamate uptake on the formation of 'H-inositol phosphates (Ps). Glutamate (100 FM) or @-methyl-DL-aspartic acid (Znh Uptake; 1 mM), an inhibitor of the high-affinity and Na+-dependent glutamate uptake process, was added into the incubation medium in the absence or presence ofeither methoxamine alone (Met/z; 25 PM) or both methoxamine (25 PM) and 2-chloroadenosine (10 PM) (Meth+ZCA).
Results, expressed as in Figure  1 , are the means + SEM of values obtained in a typical experiment performed in triplicate. *, significantly different (p < 0.01, Student's f test) from the basal production of 'H-inositol phosphates; 8, significantly different (p < 0.01) from 3H-inositol phosphate production induced by methoxamine alone. Two other independent experiments yielded similar results.
Involvement of two G-proteins. As already suggested, the noradrenaline-and 2-chloroadenosine+voked responses seem to be mediated by cy, -adrenergic receptors and purinergic receptors of the A, subtype, respectively. Indeed, methoxamine, the o(,-adrenergic agonist, reproduced the effect of noradrenaline on the formation of )H-inositol phosphates, and both responses were blocked by prasozin, a selective cu,-noradrenergic antagonist. An activation of A, adenosine receptors is probably involved in the potentiating effect of 2-chloroadenosine as indicated by the relative potencies of the adenosine agonists 5'-N-ethylcarboxamide adenosine and N,-cyclohexyladenosine and by the potent antagonistic activity of PACPX (El-Etr et al., 1989) . The involvement of A, adenosine receptors was further confirmed by the present results. In agreement with numerous studies indicating that A, receptors are coupled to G-proteins sensitive to PTX (Dolphin and Pestwich, 1985; Stiles, 1986; Cooper et al., 1989 ) the pretreatment of striatal astrocytes with the toxin was shown indeed to abolish selectively the potentiating effect of 2-chloroadenosine while it did not alter the q-adrenergicevoked production of 3H-inositol phosphates. This suggests that both types of receptors are coupled to different transduction systems (G-proteins) and effecters, the a,-adrenoceptors probably being linked to phospholipase C via a G-protein insensitive to PTX while the adenosine receptors are coupled to another effector regulated by a G-protein sensitive to this toxin (Fig. 8) .
Involvement of arachidonic acid. Several observations strongly suggest that arachidonic acid is involved in the potentiating effect of 2-chloroadenosine and are thus in favor of a coupling of A, adenosine receptors to phospholipase A2. (1) Three different compounds known to inhibit the activity of phospholipase A2, mepacrine, 4-p-bromophenacyl bromide, and cyclosporine A, suppressed the potentiating effect of 2-chloroadenosine on the methoxamine-induced formation of 3H-inositol phosphates. (2) In agreement with the well-known indirect inhibitory action of corticosterone on phospholipase A2 activity observed in numerous cell types and the presence of glucocorticoid re- ceptors on astrocytes (De Georges et al., 1987) 2-chloroadenosine was without effect when astrocytes had been pretreated for two days with corticosterone (100 nM), the natural glucocorticoid in the mouse. (3) Arachidonic acid alone (or linoleic acid) but not the C&-saturated fatty acid arachidic acid increased the formation of 3H-inositol phosphates. (4) In the presence of both methoxamine and 2-chloroadenosine, arachidonic and linoleic acids did not further increase the formation of 3H-inositol phosphates. (5) The nonmetabolizable analog of arachidonic acid, ETYA (Hawkins et al., 1985; Clark and Linden, 1986; Gerzer et al., 1986) suppressed the potentiating effect of 2-chloroadenosine.
(6) The adsorption of arachidonic acid by the addition of bovine serum albumin to the incubation medium led to a significant decrease of the 2-chloroadenosine-induced potentiating effect. (7) Finally, 2-chloroadenosine induced a release of 3H-arachidonic acid only in the presence of methoxamine.
As expected for phospholipase A2, an enzyme highly sensitive Table 3 . Permissive effect of the activation of protein kinase C upon 2-chloroadenosine-induced formation of 'H-inositol phosphates )H-inositol phosphates (% above basal) OAG -9 -c 5 2-Chloroadenosine 32 k 4 OAG + 2-chloroadenosine 112 + 1o*t An activator of protein kinase C, the diacylglycerol analog OAG (25 pg'ml), was added into the incubation medium in either the absence or presence of 2-chloroadenosine (10 PM). In the same experiment, the effect of 2-chloroadenosine alone was compared. Results, expressed as percentage above the basal formation of 'H-inositol phosphates measured in the absence of any agonist, are the means t SEM of values obtained in a typical experiment performed in triplicate. *, significantly different @ c 0.05, Student's I test) from the basal 'H-inositol phosphate production measured in the absence of any effecters; t. significantly different @ i 0.01) from the )H-inositol phosphate production induced by 2-chloroadenosine alone. Two other independent experiments yielded similar results.
Oh-NA Al Adenosine Figure 8 . Proposed mechanism for the regulation by 2-chloroadenosine of the formation of inositol phosphates in striatal astrocytes. Following the binding of methoxamine and 2-chloroadenosine on a,-adrenergic (q-NA) and A, adenosine receptors, respectively, the activity of phospholipase C (PLC) is first stimulated. The 1,4,5inositol triphosphate (ZPS) formed opens Ca z-t channels located on the endoplasmic reticulum (the inositol triphosphate-sensitive calcium stores). Diacylglycerol simultaneously formed activates protein kinase C (PKC), which by phosphorylation of a putative inhibitor (Inb) allows a lipase, likely phospholipase A2 (PLAZ), to be stimulated by 2-chloradenosine via a PTX-sensitive G-protein (G). The released arachidonic acid (AA) induces an hyperpolarization, which by increasing the driving force for Ca*+ improves the refilling of intracellular CaZ+ stores and/or potentiates the net influx of Ca*+ leading to a sustained elevation of cytosolic CaZ+ (Delumeau et al., 199 1) , which further increases phospholipase A2 activity. Due to the presence of external glutamate receptors coupled to phospholipase C on striatal astrocytes, the accumulation of external glutamate resulting from the blocking effect of arachidonic acid on glutamate uptake is responsible for the enhanced formation of inositol phosphates.
to calcium, the absence of external calcium impaired the potentiating effect of 2-chloroadenosine on the methoxamineevoked production of 3H-inositol phosphates. In fact, complementary studies, in which variations in the cytosolic concentration of calcium were estimated in single cultured striatal astrocytes using the microfluorimetric INDO-1 method provided additional evidence for the involvement of external calcium. Indeed, although 2-chloroadenosine and methoxamine alone induced only transient elevations in the cytosolic concentration of calcium, their combined application resulted in a prolonged influx of external calcium (>30 min) and this effect was immediately interrupted when calcium was removed from the extracellular medium (Delumeau et al., 199 1) .
Involvement of glutamate. It has recently been shown that arachidonic acid inhibits glutamate uptake into Mtiller cells (astrocytes) of the salamander retina (Barbour et al., 1989) and that glutamate is spontaneously released from cultured astrocytes (Kimelberg et al., 1990) . Therefore, it can be suggested that in the presence of methoxamine, 2-chloroadenosine through the release of arachidonic acid inhibits the reuptake ofglutamate and that the resulting accumulation of the amino acid in the external medium is responsible for the enhanced phospholipase C activity (Fig. 8) . This hypothesis is supported by several observations. (1) The enzymatic elimination of glutamate by the addition of GPT prevented both the enhancement by 2-chloroadenosine of the methoxamine-evoked response and the increased formation of 3H-inositol phosphates induced by the unsaturated fatty acids arachidonic acid and lineolic acid. (2) As expected, since astrocytes are known to possess glutamate receptors coupled to phospholipase C (Pearce et al., 1986) , glutamate stimulated the production of )H-inositol phosphates with an amplitude similar to that observed with arachidonic acid, and its effect was additive with that of methoxamine. (3) The stimulatory effect of glutamate on phospholipase C activity could not be seen under the combined presence of methoxamine and 2-chloroadenosine. (4) Finally, the inhibition by specific inhibitors of the high-affinity and Na+-dependent glutamate uptake process (Kimelberg et al., 1989) resulted in the formation of 3H-inositol phosphates with an amplitude similar to that observed with arachidonic acid, in both the absence and the presence of methoxamine. Moreover, in these conditions, the (Y, -adrenergic response was no longer enhanced by the combined application of 2-chloroadenosine.
The a,-adrenergic stimulation of phospholipase C exerts a permissive action on the 2-chloroadenosine+voked response. Our results strongly suggest that in striatal astrocytes the stimulation of A, adenosine receptors coupled to phospholipase A2 leads indirectly to a modulation of phospholipase C activity. Nevertheless, the cu,-adrenergic stimulation of phospholipase C exerts a permissive action on the 2-chloroadenosine-evoked response. If the adenosine receptors involved in the observed phenomenon are coupled to phospholipase A2, this enzyme must be tonically inhibited since 2-chloroadenosine alone was ineffective on the release of arachidonic acid. We suggest that the cu,-adrenergic sitmulation of phospholipase C and the expected activation of protein kinase C allow the disinhibition of phospholipase A2 activity through a phosphorylation of inhibitory components that have yet to be identified (Fig. 8) . Supporting this hypothesis, in the presence of OAG, an activator of protein kinase C, 2-chloroadenosine alone stimulated the production of )H-inositol phosphates.
In conclusion, the concentration of extracellular glutamate depends on the regulation of either the release ofglutamate from neurons or its uptake into neurons and astrocytes. Arachidonic acid has indeed been shown to decrease glutamate uptake into both cell types (Chan et al., 1983; Barbour et al., 1989) . It has also been reported that arachidonic acid can be released from striatal neurons in response to glutamate (Dumuis et al., 1988 (Dumuis et al., , 1990 . The present results indicate that arachidonic acid can also be released from astrocytes under the combined activation of A, adenosine and cy, -adrenergic receptors. Similarly, we have recently shown that somatostatin receptors coupled to phospholipase A2 are present on striatal astrocytes and that the combined activation of somatostatin and cr, -adrenergic receptors results in the formation of arachidonic acid and the same cascade of events as that observed in the present study (Marin et al., 199 1) . If arachidonic acid is really involved in long-term potentiation, this phenomenon could be linked not only to neuroneuronal interactions but also to events occurring in a more complex cellular network including astrocytes.
